Novel-13C-Spirulina-Gastric-Emptying-Breath-Test.jpg

Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test

Breath Test, gastroparesis, Latest NewsLeave a comment

Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test Brentwood, Tenn. — September 14, 2021 — Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina…

GEBT & Gastroparesis

FDA Approved Breath Test To Aid In Diagnosis of Delayed Gastric Emptying

Breath Test, gastroparesis, Latest NewsLeave a comment

Brentwood, Tenn. — September 14, 2021 — Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn…